Process for Project Evaluation and Selection Sample Clauses

Process for Project Evaluation and Selection. The Eligible Green Projects are aligned with Borrower’s sustainability and business strategy centered around helping customers electrify all aspects of their lives through solar energy systems, energy storage systems and related products and services. Borrower has internal processes to ensure continued alignment in all material respects with the Core Components and to identify, assess and mitigate environmental and social risks that could reasonably be expected to result in a Material Adverse Effect, and will utilize these processes in all material respects with regards to the Eligible Green Projects.
Sample 1Sample 2Sample 3See All (4)
AutoNDA by SimpleDocs
Process for Project Evaluation and Selection. Berlin Hyp firmly anchors the Framework in its internal process for evaluating and selecting Eligible Social Assets complying with the criteria described in Section 4.1. within its credit process. Berlin Hyp has established a Sustainable Finance Commission (“SFC”; previously Green Building Commission17) which consists of rep- resentatives from various divisions of the Bank. Among them are all departments involved in the financing/refinancing value chain: Origination, Portfolio Management, Credit, Appraisal and Treasury. Among others, Risk Controlling and Corporate Strategy are part of the SFC too. In its regular meetings the SFC discusses whether the eligibility criteria described in Section 4.1 are still in line with best market practices and relevant regulation. If not, the SFC will discuss potential changes and decide how to adapt the eligibility criteria. All potential further developments of the Eligibility Criteria are to be targeted at increasing the robustness and level of ambition of the Framework. Further develop- ments might also include the definition of social project categories beyond Affordable Housing Buildings, for instance loans to foundations who exclusively pursue charitable and non-profit making purposes in accordance with the section "Tax-Deductible Purposes" of German tax law (§52 and §53 AO).18 Berlin Hyp’s Process of Evaluation and Selection starts by proving compliance with the eligibility criteria defined in Section 4.1 at the earliest possible stage of loan origination. All Eligible Social Assets which are approved via the procedure set out in the Process of Evaluation and Selection will be included in the Social Finance Portfolio. As Berlin Hyp considers to set price incentives for Eligible Social Assets compared to loans for non-eligible residential buildings, an analysis of an asset’s compliance with the eligibility criteria described in Section 4.1 must be completed prior to pricing. To identify an asset’s compliance with the eligibility criteria, the Bank reviews documents which are regularly provided by the borrowers for the appraisal of the building and the cash flow analysis. Moreover, borrowers are asked to provide energy performance certificates or to disclose energy performance calculations. Borrowers which fall into the category “Private Housing Providers” should also provide relevant documents proving a traceable public commit- ment to affordable housing. Also, the Bank may ask borrowers to provide relevant addition...
Sample 1
Process for Project Evaluation and Selection. The Eligible Green Projects are aligned with Borrower’s sustainability and business strategy centered around helping customers electrify all aspects of their lives through solar energy systems, energy storage systems and related products and services. Borrower has internal processes to ensure continued alignment in all material respects with the Core Components and to identify, assess and mitigate environmental and social risks that could reasonably be expected to result in a Material Adverse Effect, and will utilize these processes in all material respects with regards to the Eligible Green Projects. [***] = Certain information has been excluded from this exhibit because it is both not material and would likely cause harm to the company if publicly disclosed.
Sample 1
Process for Project Evaluation and Selection. Eligible Green Projects are identified and selected via a process that involves participants from various functional areas. We have set up a Sustainable Development Management Committee (‘‘SDMC’’) to oversee the Group’s ESG and Sustainability reporting. SDMC will also resume the responsibility of Green Financing Transactions. SDMC is composed of representatives from the below departments with the required level of expertise and seniority: . Investment and Finance Center . Financial & Capital Center . Corporate Executive Center . Operation Development Center . Human Resources Center . Property Construction Centre . Risk Control Center SDMC will review and select Eligible Green Projects every 12 months. SDMC will ensure the selected Eligible Green Projects to comply with the Use of Proceeds as stated in this section and the environmental guidance under the ICMA Green Bond Principles 2018 and the APLMA Green Loan Principles 2018 that are applicable to us. MANAGEMENT OF PROCEEDS Our finance team will track the net proceeds of each Green Financing Transaction using an internal register to record the following information: . Type of funding transaction: key information including details such as issuer/ borrower entity, transaction date, number of transactions, principal amount of proceeds, repayment or amortization profile, maturity date, interest or coupon, and the ISIN number in case of bond transactions. . Allocation of use of proceeds: key information including amount of proceeds allocated to each Eligible Green Project and the balance of unallocated proceeds. We commit to allocating all proceeds from the Green Financing Transactions to Eligible Green Projects on a best effort basis within one year of issuance in accordance with the evaluation and selection process set out above. Pending allocation, the net proceeds from the Green Financing Transactions issued may be invested in cash or cash equivalents, or used to repay existing borrowings under our general credit facilities.
Sample 1
Process for Project Evaluation and Selection. The Issuer’s Green Financing Working Group (“GFWG”) is responsible for the management of the Framework and the compliance of all financing instruments issued under the Framework. The GFWG consists of senior representatives from the following departments: • Treasury Department • Finance & Accounting • Risk Management • Wholesale Credit Department • Retail Credit Acquisition Department The GFWG may be supplemented from time to time, or expanded, by the inclusion of representatives from other relevant teams. For new issuances, Treasury Department will coordinate and compile the submission of identified projects for the GFWG’s review. The identified projects’ environmental credentials will be obtained and confirmed via liaison with relevant business partners and internal departments. The GFWG will consider potential projects, assess their eligibility, and approve those that qualify as eligible projects. The GFWG will consider all proposed projects holistically and aim to ensure that all approved projects financed under the Framework have positive environmental impact for stakeholders and the society. As part of the assessment process, the GFWG will consider: • any potential environmental or social risks; • the alignment of the projects with the Issuer’s sustainability strategies and policies, including SDG priorities; and • the projects’ compliance with relevant local, national, and/or international regulatory requirements and market standards, including those on environmental protection. The proceeds of each sustainable debt instrument can be used for both the financing and/or refinancing of eligible projects. A look-back period of three years will apply for refinancing. The GFWG will review the eligibility of those projects every year. Should a project be considered by GFWG to be no longer meeting the criteria detailed above or is subject to postponement, cancelation or divestment, the Issuer is committed to re-allocating the proceeds to ensure the full amount of the proceeds are allocated to eligible projects. Such monitoring will be implemented throughout the life of the GFTs.
Sample 1

Related to Process for Project Evaluation and Selection

  • Information Systems Acquisition Development and Maintenance Security of System Files. To protect City Information Processing Systems and system files containing information, Service Provider will ensure that access to source code is restricted to authorized users whose specific job function necessitates such access.

  • ANALYSIS AND MONITORING The Custodian shall (a) provide the Fund (or its duly-authorized investment manager or investment adviser) with an analysis of the custody risks associated with maintaining assets with the Eligible Securities Depositories set forth on Schedule B hereto in accordance with section (a)(1)(i)(A) of Rule 17f-7, and (b) monitor such risks on a continuing basis, and promptly notify the Fund (or its duly-authorized investment manager or investment adviser) of any material change in such risks, in accordance with section (a)(1)(i)(B) of Rule 17f-7.

  • Forecasting Manager and Sprint PCS will work cooperatively to generate mutually acceptable forecasts of important business metrics including traffic volumes, handset sales, subscribers and Collected Revenues for the Sprint PCS Products and Services. The forecasts are for planning purposes only and do not constitute Manager's obligation to meet the quantities forecast.

  • Commercialization Reports Throughout the term of this Agreement and during the Sell-Off Period, and within thirty (30) days of December 31st of each year, Company will deliver to University written reports of Company’s and Sublicensees’ efforts and plans to develop and commercialize the innovations covered by the Licensed Rights and to make and sell Licensed Products. Company will have no obligation to prepare commercialization reports in years where (a) Company delivers to University a written Sales Report with active sales, and (b) Company has fulfilled all Performance Milestones. In relation to each of the Performance Milestones each commercialization report will include sufficient information to demonstrate achievement of those Performance Milestones and will set out timeframes and plans for achieving those Performance Milestones which have not yet been met.

  • Research Analyst Independence The Company acknowledges that the Underwriters’ research analysts and research departments are required to be independent from their respective investment banking divisions and are subject to certain regulations and internal policies, and that such Underwriters’ research analysts may hold views and make statements or investment recommendations and/or publish research reports with respect to the Company and/or the offering that differ from the views of their respective investment banking divisions. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against the Underwriters with respect to any conflict of interest that may arise from the fact that the views expressed by their independent research analysts and research departments may be different from or inconsistent with the views or advice communicated to the Company by such Underwriters’ investment banking divisions. The Company acknowledges that each of the Underwriters is a full service securities firm and as such from time to time, subject to applicable securities laws, may effect transactions for its own account or the account of its customers and hold long or short positions in debt or equity securities of the companies that may be the subject of the transactions contemplated by this Agreement.

  • Marketing Plans Contractor and the Exchange recognize that Enrollees and other health care consumers benefit from efforts relating to outreach activities designed to increase heath awareness and encourage enrollment. The parties shall share marketing plans on an annual basis and with respect to periodic updates of material changes. The marketing plans of the Exchange and Contractor shall include proposed and actual marketing approaches, messaging and channels and provide samples of any planned marketing materials and related collateral as well as planned, and when completed, expenses for the marketing budget. The Contractor shall include this information for both the Exchange and the outside individual market. The Exchange shall treat all marketing information provided under this Section as confidential information consistent with Section 1.4.1. The obligation of the Exchange to maintain confidentiality of this information shall survive termination or expiration of this Agreement.

  • Tests and Preclinical and Clinical Trials The studies, tests and preclinical and clinical trials conducted by or, to the Company’s knowledge, on behalf of the Company were and, if still ongoing, are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional scientific standards and all Authorizations and Applicable Laws, including, without limitation, the Federal Food, Drug and Cosmetic Act and the rules and regulations promulgated thereunder (collectively, “FFDCA”); the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the General Disclosure Package and the Prospectus are, to the Company’s knowledge, accurate in all material respects and fairly present the data derived from such studies, tests and trials; except to the extent disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, the Company is not aware of any studies, tests or trials, the results of which the Company believes reasonably call into question the study, test, or trial results described or referred to in the Registration Statement, the General Disclosure Package and the Prospectus when viewed in the context in which such results are described and the clinical state of development; and, except to the extent disclosed in the Registration Statement, the General Disclosure Package or the Prospectus, neither the Company nor any Subsidiary has received any notices or correspondence from the FDA or any Governmental Entity requiring the termination or suspension of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company, other than ordinary course communications with respect to modifications in connection with the design and implementation of such trials, copies of which communications have been made available to you.

  • Marketing Plan The MCP shall submit an annual marketing plan to ODM that includes all planned activities for promoting membership in or increasing awareness of the MCP. The marketing plan submission shall include an attestation by the MCP that the plan is accurate is not intended to mislead, confuse or defraud the eligible individuals or ODM.

  • Manufacturing and Supply Genentech shall be responsible for manufacturing and supplying Licensed Products for clinical use and commercial sale in the Genentech Field.

Time is Money Join Law Insider Premium to draft better contracts faster.